A
Azza B. El-Remessy
Researcher at Charlie Norwood VA Medical Center
Publications - 125
Citations - 6276
Azza B. El-Remessy is an academic researcher from Charlie Norwood VA Medical Center. The author has contributed to research in topics: Peroxynitrite & Vascular endothelial growth factor. The author has an hindex of 44, co-authored 123 publications receiving 5746 citations. Previous affiliations of Azza B. El-Remessy include Discovery Institute & University of South Carolina.
Papers
More filters
Journal ArticleDOI
Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity
Maritza J. Romero,D.H. Platt,Huda E. Tawfik,M. Labazi,Azza B. El-Remessy,Manuela Bartoli,Ruth B. Caldwell,Robert W. Caldwell +7 more
TL;DR: It is indicated that increased arginase activity in diabetes contributes to vascular endothelial dysfunction by decreasing l-arginine availability to NO synthase.
Journal ArticleDOI
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
Ruth B. Caldwell,Manuela Bartoli,M. Ali Behzadian,Azza B. El-Remessy,Mohamed Al-Shabrawey,D.H. Platt,R. William Caldwell +6 more
TL;DR: The cellular and molecular alterations that characterize experimental models of diabetes are considered in relation to the influence of high glucose‐mediated oxidative stress on VEGF expression and on the mechanisms of V EGF's actions under hyperglycemic induction.
Journal ArticleDOI
Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
Ruth B. Caldwell,Manuela Bartoli,M. Ali Behzadian,Azza B. El-Remessy,Mohamed Al-Shabrawey,D.H. Platt,Gregory I. Liou,R. William Caldwell +7 more
TL;DR: Cellular and molecular alterations seen in diabetic models are considered in the context of high glucose-mediated oxidative stress effects on VEGF expression and action and potential therapeutic strategies for preventing V EGF overexpression or blocking its pathological actions in the diabetic retina are considered.
Journal ArticleDOI
Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity : Involvement of Peroxynitrite
Azza B. El-Remessy,Ibrahim E. Khalil,Suraporn Matragoon,Gamal Abou-Mohamed,Nai Jer Tsai,Penny Roon,Ruth B. Caldwell,Robert W. Caldwell,Keith Green,Gregory I. Liou +9 more
TL;DR: The potential use of CBD as a novel topical therapy for the treatment of glaucoma is suggested and the hypothesis that glutamate causes apoptosis of retinal neurons via the excessive formation of peroxynitrite is tested.
Journal ArticleDOI
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Azza B. El-Remessy,Mohamed Al-Shabrawey,Y. Khalifa,N.-T. Tsai,Ruth B. Caldwell,Gregory I. Liou +5 more
TL;DR: In this article, the effects of a nonpsychotropic cannabinoid, cannabidiol (CBD), were examined in streptozotocin-induced diabetic rats after 1, 2, or 4 weeks and CBD treatment significantly reduced oxidative stress; decreased the levels of tumor necrosis factor-α, vascular endothelial growth factor, and intercellular adhesion molecule-1; and prevented retinal cell death and vascular hyperpermeability in the diabetic retina.